Roche’s Spark Therapeutics unit is pitching $575 million into a new gene therapy manufacturing facility at Drexel University’s Philadelphia campus that will work towards the next generation of genetic medicines. The initial investment will fund the construction of a new gene therapy innovation center to provide collaboration opportunities between Spark and Drexel University. Source: Fierce Biotech 17/12/2021